Malignant tumor of peripheral nerve sheath in the thoracolumbar region in a cat

Background: In veterinary medicine, peripheral nerve tumors (PNST) are classified from the cellular pattern and as benign and malignant (MPNST). The majorities of cases are benign and usually involve the skin and subcutaneous tissue of the head, neck, and limbs. Animals with MPTNS usually have spinal cord and spinal canal involvement and are also described in the small and large intestine, oral cavity, perirenal region, and urinary bladder. Treatment is performed according to the location of the neoplasm and metastasis is rarely described. The present article aims to report a case of a malignant tumor in the peripheral nerve sheath of a cat. Case: A 8-year-old domestic cat was presented with a history of progressive paresis in the pelvic limbs. On neurological evaluation, proprioceptive ataxia and proprioception deficit in the pelvic limbs were observed, suggestive of thoracolumbar injury. Blood work and serum biochemistry showed results within the reference for the species and the bi-directional immunochromatography test for FIV and FeLV were negative. The radiographs of the thoracolumbar segment did not show significant changes. Myelography with iodinated contrast and collection of cerebrospinal fluid (CSF) were performed. On myelography examination, iodinated contrast loss was found between the 6th and 7th thoracic vertebrae, while the CSF analysis was normal. The patient underwent laminectomy and durotomy for excision of a mass found dorsally to the spinal cord, with intradural location. The tumor was sent for histopathological examination. Microscopic analysis showed neoplastic proliferation of spindle-shaped cells with predominance of the Antoni A pattern. Immunohistochemical analysis demonstrated intense cytoplasmic staining of the neoplastic cells for vimentin and S100 protein. Based on these findings, the diagnosis of malignant peripheral nerve sheath tumor was made. Radiotherapy was suggested as adjuvant treatment after surgical procedure. However, the owner refuse to follow this recommendation due to cost restriction. The patient had a satisfactory clinical recovery, he has no longer presented proprioceptive ataxia or proprioception deficits in three months after the surgical procedure. Discussion: In the case described, the feline patient presented a history, clinical signs, and findings in the myelography exam related to MPNST in the region of the vertebral canal. This neoplasm usually involves the spinal canal or spinal cord, but has been described in other locations, such in the small and large intestine, oral cavity, perirenal region, and urinary bladder. Based on the findings of the physical examination and complementary exams, a surgical procedure was recommended. Then, laminectomy and dutoromy were performed to remove the mass. The treatment described in the literature in cases of MPTNS is surgery, which can be curative, but in some cases, the use of radiotherapy may be necessary. The histological patterns observed in this neoplasm are the Antoni A and B, in the case described the Antoni A pattern was observed. The definitive diagnosis was made by immunohistochemistry with vimentin and S100 protein. MPNST are few described in the thoracolumbar region in cats. The surgical treatment was curative, where improvement of the clinical signs could be observed three months after surgery. In addition, monitoring of patients is recommended to ascertain relapses and metastases.

Analysis of nuclear maturation, DNA damage and repair gene expression of bovine oocyte and cumulus cells submitted to ionizing radiation'

Radiotherapy causes destruction of tumor cells, but also threatens the integrity and survival of surrounding normal cells. Then, woman submitted to irradiation for cancer treatment may present permanent ovary damage, resulting in impaired fertility. The objective of this study was to investigate the effects of therapeutic doses of ionizing radiation (IR), used for ovarian cancer treatment in humans, on bovine cumulus-oocyte complexes (COCs) as experimental model. Bovine ovaries were exposed to 0.9 Gy, 1.8 Gy, 3.6 Gy or 18.6 Gy IR, and then COCs were collected and used to evaluate: (a) oocyte nuclear maturation; (b) presence of phosphorylated H2A.X (γH2AX), as an indicator of DNA double-strand breaks (DSBs); and (c) expression of genes involved in DNA repair (TP53BP1, RAD52, ATM, XRCC6 and XRCC5) and apoptosis (BAX). The radiation doses tested in this study had no detrimental effects on nuclear maturation and did not increase γH2AX in the oocytes. However, IR treatment altered the mRNA abundance of RAD52 (RAD52 homolog, DNA repair protein) and BAX (BCL2-associated X protein). We conclude that although IR doses had no apparent effect on oocyte nuclear maturation and DNA damage, molecular pathways involved in DNA repair and apoptosis were affected by IR exposure in cumulus cells.(AU)

Cytotoxicity of iodine-131 radiopharmaceutical in tumor and non-tumor human cells and radioprotection by integral juices of Vitis labrusca L / Citotoxicidade do radiofarmacêutico iodo-131 em células humanas tumorais e não tumorais e radioprotecção por sucos integrais de Vitis labrusca L

Iodine-131 (I-131) radioisotope it causes the formation of free radicals, which lead to the formation of cell lesions and the reduction of cell viability. Thus, the use of radioprotectors, especially those from natural sources, which reduce the effects of radiation to healthy tissues, while maintaining the sensitivity of tumor cells, stands out. The objective of the present study was to evaluate the cytoprotective/radioprotective effects of whole grape juices manufactured from the conventional or organic production systems, whether or not exposed to ultraviolet (UV-C) light irradiation. The results showed that I-131 presented a cytotoxic effect on human hepatocellular cells (HepG2/C3A) at concentrations above 1.85 MBq/mL, after 24 and 48 hours of treatment, though all concentrations (0.0037 to 7.40 MBq/mL) were cytotoxic to non-tumor human lung fibroblast (MCR-5) cells, after 48 hours. However, grape juices (10 and 20 µL/mL) did not interfere with the cytotoxic effect of the therapeutic dose of I-131 on tumor cells within 48 hours of treatment, while protecting the non-tumor cells, probably due to its high antioxidant activity. In accordance with their nutraceutical potential, antioxidant and radioprotective activity, these data stimulate in vivo studies on the use of natural products as radioprotectants, such as grape juice, in order to confirm the positive beneficial potential in living organisms.

O radioisótopo iodo-131 (I-131) causa a formação de radicais livres, que levam à formação de lesões celulares e redução da viabilidade celular. Assim, destaca-se a utilização de radioprotetores, principalmente de origem natural, que reduzem os efeitos da radiação nos tecidos saudáveis, mantendo a sensibilidade das células tumorais. O objetivo do presente estudo foi avaliar os efeitos citoprotetores/radioprotetores de sucos de uva integral fabricados em sistemas de produção convencional ou orgânico, expostos ou não à radiação ultravioleta (UV-C). Os resultados mostraram que o I-131 apresentou efeito citotóxico nas células hepatocelulares humanas (HepG2/C3A) em concentrações acima de 1,85 MBq/mL, após 24 e 48 horas de tratamento, embora todas as concentrações (0,0037 a 7,40 MBq/mL) fossem citotóxicas para células de fibroblasto de pulmão humano não tumoral (MCR-5), após 48 horas. No entanto, os sucos de uva (10 e 20 µL/mL) não interferiram no efeito citotóxico da dose terapêutica de I-131 nas células tumorais em 48 horas de tratamento, protegendo as células não tumorais, provavelmente devido ao seu alto poder antioxidante. atividade. De acordo com seu potencial nutracêutico, atividade antioxidante e radioprotetora, esses dados estimulam estudos in vivo sobre o uso de produtos naturais como radioprotetores, como o suco de uva, a fim de confirmar o potencial benéfico positivo em organismos vivos.

Meningioma intracraniano em cão - tratamento com radioterapia / Intracranial meningioma in a dog - treatment with radiotherapy

Background: The most common primary brain neoplasm is meningioma. Dolichocephalic breeds are predisposed and there is no sexual predilection. Clinical signs depend on the location and size of the tumor and have a progressive course. Primary treatement includes surgery, radiotherapy or both. This study aimed to describe the treatment of a dog with suspected intracranial meningioma with definitive radiotherapy, which resulted in significant clinical improvement and prolonged survival. Case: A 9-year-old Shetland Shepherd bitch was diagnosed with a head tilt to the left side that progressed over a few weeks. She previously received corticosteroid therapy, which resulted a clinical improvement that worsened after treatment was discontinued. Computed tomography revealed an extra-axial brain mass in the caudal fossa, lateralized to the right, welldelimited, and measuring approximately 1.5 × 1.4 × 1.7 cm, suggestive of intracranial meningioma. The patient was treated with radiotherapy using Cobalt-60 equipment, with 18 daily fractions of 2.5 Gy at a total dose of 45 Gy using parallel and opposite technique fields. A new tomography performed 30 days after treatment showed a remission of 85% of the initial brain mass measuring approximately 0.9 × 1.0 × 0.5 cm, as well as complete resolution of the clinical signs initially presented. After 14 months, the patient presented with signs of lethargy and ataxia and was medicated with hydroxyurea at a dose of 50 mg/kg 3 times a week and corticosteroid therapy. However, the patient's neurological condition deteriorated, and she was subjected to reirradiation using the same protocol used previously, which resulted in clinical improvement and a 54% reduction in tumor volume on magnetic resonance. As a late side effect, only permanent alopecia in the irradiated region was observed. The patient died of disease 330 days after the second course of radiotherapy, with a total survival time of 1087 days. Discussion: Meningiomas are extra-axial neoplasms of the central nervous system that grow inside the dura mater. The literature shows that meningiomas are more common in dolichocephalic races with a mean age of 9 years, which supports our findings. Meningiomas most commonly affect the cortical thalamus and cerebellopontine region in dogs, which are normally associated with vestibular symptoms, as seen in this case. Diencephalic damage can result in vestibular signals since the thalamus functions as a relay station for vestibular afferent stimuli that are relayed to the cerebral cortex. In addition to the vestibular syndrome, common clinical signs associated with meningiomas in dogs include seizures, behavioral changes, and walking in circles, which are frequently misinterpreted due to tumor-induced side effects, such as cerebral edema, obstructive hydrocephalus, and cerebral hernia. Advanced imaging techniques should be used to diagnose intracranial neoplasms. In this case, computed tomography was critical for diagnosis and treatment planning. Meningioma treatment may comprise palliative measures, surgery, and radiotherapy. Radiotherapy as a single treatment can improve the quality of life with a decrease in clinical signs and a median survival time of approximately 250-536 days, as reported in the literature. Hydroxyurea can be a therapeutic option in inoperable cases and for patients with clinical limitations to undergo successive anesthesia during radiotherapy. Its most serious side effect is progressive myelosuppression. It can cause temporary partial tumor remission and improvement in clinical signs. As previously stated, radiotherapy can be an effective primary treatment option for treating intracranial meningiomas in dogs, with significant improvement in neurological clinical signs and mild side effects.

Utilização da manufatura aditiva (impressão em 3d) no tratamento de osteossarcoma vertebral em cão submetido a vertebrectomia lombar: relato de caso

El osteosarcoma es una de las neoplasias óseas más comúnmente reportadas en medicina veterinaria, principalmente en perros de raza grande y gigante, siendo que la forma vertebral tiene importante escenario clínico presentando el 5% del total de reportes. Tiene un pronóstico desfavorable y un tiempo de supervivencia corto. La presentación clínica es variable y pueden observarse desde signos de dolor intenso hasta déficits neurológicos como resultado de la afectación medular progresiva. El diagnóstico puede realizarse mediante imágenes con radiografía o tomografía computarizada, y mediante análisis de laboratorio de citopatología o histopatología, siendo este último preferible para la clasificación del tumor. La resección parcial del tumor es una forma de tratamiento paliativo, indicada en algunos casos para aliviar temporalmente los signos clínicos relacionados con el dolor y los déficits neurológicos. Sin embargo, cuando hay posibilidad terapéutica, la escisión completa proporciona un mejor pronóstico y tiempo de supervivencia, principalmente cuando se asocia con quimioterapia o radioterapia. Mediante el procedimiento de la vertebrectomía, es necesaria la estabilización quirúrgica, que puede realizarse respetando los principios para la estabilización vertebral por traumatismo, siendo necesaria la colocación de un espaciador vertebral para evitar el colapso medular. Se han propu

Osteosarcoma is one of the most commonly reported bone neoplasms in veterinary medicine, especially in large and giant breed dogs, and the vertebral form has an important clinical scenario presenting 5% of the total reports. This has an unfavorable prognosis and a short survival time.  The clinical presentation is variable and signs of severe pain to neurological deficits can be observed as a result of progressive spinal cord involvement. The diagnosis can be made by imaging with radiography or computed tomography, and by laboratory analysis of cytopathology or histopathology, the latter being preferable for tumor classification. Partial tumor resection is a palliative form of treatment, indicated in some cases to temporarily relieve clinical signs related to pain and neurological deficits. However, when there is therapeutic possibility, complete excision provides better prognosis and survival time, especially when associated with chemotherapy or radiotherapy. Through the vertebrectomy procedure, surgical stabilization is necessary and can be performed following the principles for vertebral stabilization due to trauma, with the placement of a vertebral spacer being necessary to prevent spinal collapse. Several materials have been proposed for the manufacture of the spinal spacer. Additive manufacturing, also known as 3D printing, has transformed the concept of rapid pr

O osteossarcoma é uma das neoplasias ósseas mais comumente relatadas na medicina veterinária, principalmente em cães de raça grande e gigante, sendo que a forma vertebral possui importante cenário clínico apresentando 5% do total de relatos. Este possui um prognóstico desfavorável e tempo de sobrevida pequeno. A apresentação clínica é variável e podem ser observados sinais de dor intensa a déficits neurológicos em decorrência do envolvimento medular progressivo. O diagnóstico pode ser realizado por imagens através de radiografia ou tomografia computadorizada, e por análises laboratoriais de citopatologia ou histopatologia, sendo o último preferível para classificação de tumores. A ressecção tumoral parcial é uma forma paliativa de tratamento, indicada em alguns casos para aliviar temporariamente os sinais clínicos relacionados a dor e déficits neurológicos. Contudo, quando há possibilidade terapêutica, a excisão completa fornece melhor prognóstico e tempo de sobrevida, principalmente quando associada a quimioterapia ou radioterapia. Mediante procedimento de vertebrectomia, a estabilização cirúrgica é necessária, podendo ser realizada respeitando os princípios para estabilização vertebral por trauma, sendo necessário a colocação de um espaçador vertebral para evitar o colabamento medular. Diversos materiais foram propostos para a confecção do espaçador vertebral. A manufatura ad

Carcinoma uretral primário em uma cadela - tratamento multimodal / Primary urethral carcinoma in a bitch - multimodal treatment

Background: Urethral tumors are uncommon in canines, represented predominantly by transitional cell carcinoma, marked by aggressive behavior associated with short life expectancy. Definitive diagnosis is achieved by histopathological analysis. Surgery associated with chemotherapy is the main therapeutic alternative. The aim of this paper is to report a case of primary transitional cell carcinoma of the urethra in a bitch, submitted to surgical treatment associated with conventional adjuvant chemotherapy and metronomic chemotherapy, achieving survival of 21 months, to date. Case: A 12-year-old bitch mixed breed was admitted at the Veterinary Hospital of Federal Rural University of Rio de Janeiro (UFRRJ), manifesting hematuria and urinary incontinence for one month. Physical examination indicated that vital parameters were within normal limits. Laboratory tests of blood count and serum biochemistry, urinalysis, culture, urinary antibiogram, and abdominal ultrasound were performed. The ultrasound image suggested a neoplastic urethral process. Because of the suspicion of neoplasm, a thoracic X-ray was performed, showing no evidence of metastasis. Computed tomography (CT) of the abdominal region was performed, revealing an expansive lesion in the urethra with loss of definition of the walls and urethral lumen extending to the level of the pelvic floor, measuring about 2.9 x 1.4 x 1.2 cm. After preanesthetic exams, the animal underwent resection and surgical anastomosis of the affected urethral region. The sectioned tissue was sent for histopathological analysis, with diagnosis of transitional cell carcinoma. Adjuvant chemotherapy was performed using carboplatin at a dose of 250 mg/m², intravenously, every 21 days for 6 sessions. After completing the protocol, abdominal ultrasonography was performed again, which showed a cicatricial process in the urethral region of the surgical excision, with no sign of tumor recurrence. A metronomic chemotherapy protocol was then started with cyclophosphamide at a dose of 15 mg/m², daily for 6 months, with periodic oncological follow-up. At the end of the period, the animal remained under periodic follow-up with ultrasound exams performed at 2-month intervals, and has been free from recurrence for 21 months until now. Discussion: Urethral neoplasms account for 0.5 - 2% of all canine tumors, and are represented mostly by transitional cell carcinomas. Clinical signs of urinary obstruction and hematuria are the most common, as reported in the patient in question. The definitive diagnosis is by histopathological examination. However, imaging tests such as computed tomography are important in the initial investigation and surgical planning. The indicated treatment is surgical resection of the mass with subsequent adjuvant chemotherapy or radiotherapy. The chemotherapy protocol associating cisplatin and piroxicam can achieve remission rates of 70%, but this association has a high nephrotoxic effect. In the present case, cisplatin was replaced by carboplatin in order to reduce the nephrotoxic effects of chemotherapy. The metronomic protocol using cyclophosphamide was used as maintenance therapy, at the end of the conventional chemotherapy protocol. Survival achieved was longer than that described in the literature in cases of transitional cell carcinomas in the urethral region. Therefore, multimodal therapy using surgery associated with conventional and metronomic chemotherapy, is an option in canines with urethral carcinoma.

Primary intestinal fibrosarcoma in cats

Background: Fibrosarcomas are malignant neoplasms of mesenchymal origin and can have different symptoms depending on the species, age, location and etiopathogenesis. Intestinal tumors in domestic cats are common and the small intestine is the most common site; however, fibrosarcomas are rare in the intestine of all animal species. This work reports intestinal fibrosarcoma in 2 domestic cats and aims to clarify and present information concerning this neoplastic type in the gastrointestinal tract of this species. Cases: We report 2 cases of intestinal fibrosarcoma in domestic felines (Felis catus). Cat 1. A 14-year-old female Persian breed, domestic cat, was taken to the Feline Sector of the Veterinary Hospital of Small Animals (HVPA) of the Federal Rural University of Rio de Janeiro (UFRRJ). The main complaint was chronic constipation and rectal prolapse. The clinical examination revealed an ulcerated mass, measuring 4.0 cm x 1.7 cm. Cat 2. A 10-year-old female undefined breed, domestic cat, was taken to the private clinic. The main complaint was diarrhea with bloody and rectal prolapse. The clinical examination revealed nodule measuring 2.5 cm in diameter. The surgical option decided upon was to use the rectal pull-through technique in both animals. The patients had no trans-surgical or postoperative complications. The material collected during the surgical interventions was analyzed macroscopically and fixed in 10% buffered formalin for 24 h and then sent to the Histopathology Laboratory of the Pathological Anatomy Sector (SAP) at UFRRJ for the cat 1 and in private laboratory for the cat 2. After fixation, it was cleaved for routine microscope exam using Hematoxylin and Eosin (HE) stains and for the histochemical method of Masson's Trichrome staining technique. Complementary immunohistochemistry tests and electron microscopy were also performed. The patients were followed up clinically, showing complete remission of the clinical signs and survival for approximately 1 year after the neoplastic resection. Discussion: There are few reports of intestinal fibrosarcomas in veterinary medicine, therefore, little is known about racial predilection, age, sex or biological behavior. As far as these authors know, this is the 6th and 7th report of this neoplasm with a primary site in the large intestine in this species. The morphological diagnosis of fibrosarcoma is relatively simple, whereas, in some cases the differential diagnosis for tumors of the peripheral nerve sheath, leiomyosarcomas and gastrointestinal stromal tumor (GIST) can be extremely difficult. The immunohistochemistry technique in these cases may not be particularly useful. The fibrosarcoma diagnosis was also confirmed by electron microscopy since no evidence was found that could lead to a neuronal origin, thus excluding tumors such as neurofibrosarcoma and schawnoma, corroborating the immunohistochemical examination. The surgical management of tumor resection with wide safety margins (minimum 2 cm) remains the "gold standard" therapy for dealing with fibrosarcomas since they have a low response rate to chemotherapy and radiotherapy and the use of these therapies as an adjuvant is controversial. The advantages of this technique are related to the surgical time, simplicity, easy access and reduction in the risk of abdominal contamination. Histopathological, immunohistochemistry and electron microscopy evaluations were sufficient to enable the diagnosis of an intestinal fibrosarcoma in both cats. The occurrence of this neoplasm with intestinal involvement in the feline species is rare; therefore, this description is important as it provides information about epidemiology, associated signs, differential diagnoses, biological behavior, treatment and prognosis.

Utilização da manufatura aditiva (impressão em 3D) no tratamento de osteossarcoma vertebral em cão submetido a vertebrectomia lombar: relato de caso / Use of additive manufacturing (3D printing) in the treatment of vertebral osteosarcoma in dogs submitted to lumbar vertebrectomy: case report / Uso de la fabricación aditiva (impresión 3D) en el tratamiento del osteosarcoma vertebral en perros sometidos a vertebrectomía lumbar: caso clínico

O osteossarcoma é uma das neoplasias ósseas mais comumente relatadas na medicina veterinária, principalmente em cães de raça grande e gigante, sendo que a forma vertebral possui importante cenário clínico apresentando 5% do total de relatos. Este possui um prognóstico desfavorável e tempo de sobrevida pequeno. A apresentação clínica é variável e podem ser observados sinais de dor intensa a déficits neurológicos em decorrência do envolvimento medular progressivo. O diagnóstico pode ser realizado por imagens através de radiografia ou tomografia computadorizada, e por análises laboratoriais de citopatologia ou histopatologia, sendo o último preferível para classificação de tumores. A ressecção tumoral parcial é uma forma paliativa de tratamento, indicada em alguns casos para aliviar temporariamente os sinais clínicos relacionados a dor e déficits neurológicos. Contudo, quando há possibilidade terapêutica, a excisão completa fornece melhor prognóstico e tempo de sobrevida, principalmente quando associada a quimioterapia ou radioterapia. Mediante procedimento de vertebrectomia, a estabilização cirúrgica é necessária, podendo ser realizada respeitando os princípios para estabilização vertebral por trauma, sendo necessária a colocação de um espaçador vertebral para evitar o colabamento medular. Diversos materiais foram propostos para a confecção do espaçador vertebral. A manufatura aditiva, também conhecida como impressão 3D, tem transformado o conceito de prototipagem rápida em realidade, devido a habilidade de fabricar peças geométricas específicas de alta complexidade e de forma rápida, permitindo elaborar protótipos para uso pré ou transoperatórios em cirurgias ortopédicas de alta complexidade. O polietileno tereftalato glicol (PETG), por ser um termoplástico de alta resistência, não-biodegradável, biocompatível e de baixo custo é foco desse trabalho no desenvolvimento do espaçador vertebral como estabilizador em um procedimento de vertebrectomia em cão.

Osteosarcoma is one of the most commonly reported bone neoplasms in veterinary medicine, especially in large and giant breed dogs, and the vertebral form has an important clinical scenario presenting 5% of the total reports. This has an unfavorable prognosis and a short survival time. The clinical presentation is variable and signs of severe pain to neurological deficits can be observed as a result of progressive spinal cord involvement. The diagnosis can be made by imaging with radiography or computed tomography, and by laboratory analysis of cytopathology or histopathology, the latter being preferable for tumor classification. Partial tumor resection is a palliative form of treatment, indicated in some cases to temporarily relieve clinical signs related to pain and neurological deficits. However, when there is therapeutic possibility, complete excision provides better prognosis and survival time, especially when associated with chemotherapy or radiotherapy. Through the vertebrectomy procedure, surgical stabilization is necessary and can be performed following the principles for vertebral stabilization due to trauma, with the placement of a vertebral spacer being necessary to prevent spinal collapse. Several materials have been proposed for the manufacture of the spinal spacer. Additive manufacturing, also known as 3D printing, has transformed the concept of rapid prototyping into reality, due to its ability to quickly manufacture specific geometric parts of high complexity, allowing the elaboration of prototypes for pre- or trans-operative use in highly complex orthopedic surgeries. Polyethylene terephthalate glycol (PETG), being a high-strength, non-biodegradable, biocompatible and low-cost thermoplastic, is the focus of this work in the development of the vertebral spacer as a stabilizer in a vertebrectomy procedure in a dog.

El osteosarcoma es una de las neoplasias óseas más comúnmente reportadas en medicina veterinaria, principalmente en perros de raza grande y gigante, siendo que la forma vertebral tiene importante escenario clínico presentando el 5% del total de reportes. Tiene un pronóstico desfavorable y un tiempo de supervivencia corto. La presentación clínica es variable y pueden observarse desde signos de dolor intenso hasta déficits neurológicos como resultado de la afectación medular progresiva. El diagnóstico puede realizarse mediante imágenes con radiografía o tomografía computarizada, y mediante análisis de laboratorio de citopatología o histopatología, siendo este último preferible para la clasificación del tumor. La resección parcial del tumor es una forma de tratamiento paliativo, indicada en algunos casos para aliviar temporalmente los signos clínicos relacionados con el dolor y los déficits neurológicos. Sin embargo, cuando hay posibilidad terapéutica, la escisión completa proporciona un mejor pronóstico y tiempo de supervivencia, principalmente cuando se asocia con quimioterapia o radioterapia. Mediante el procedimiento de la vertebrectomía, es necesaria la estabilización quirúrgica, que puede realizarse respetando los principios para la estabilización vertebral por traumatismo, siendo necesaria la colocación de un espaciador vertebral para evitar el colapso medular. Se han propuesto varios materiales para la fabricación del espaciador vertebral. La fabricación aditiva, también conocida como impresión 3D, ha transformado el concepto de prototipado rápido en una realidad, debido a la capacidad de fabricar piezas geométricas específicas de gran complejidad y con rapidez, lo que permite la elaboración de prototipos para su uso pre o trans-operatorio en cirugías ortopédicas de gran complejidad. El polietileno tereftalato glicol (PETG), por ser un termoplástico de alta resistencia, no biodegradable, biocompatible y de bajo costo es el foco de este trabajo en el desarrollo del espaciador vertebral como estabilizador en un procedimiento de vertebrectomía en un perro.

Tumor Venéreo Transmissível (TVT) nasal com metástase óssea em um cão / Nasal transmissible venereal tumor (TVT) with bone metastasis in a dog

Background: Transmissible venereal tumor (TVT) is a highly contagious round cell neoplasm that affects dogs, and itis usually transmitted through coitus. The tumor is mainly located in the genital area; however, the neoplasm can also beextragenital, affecting the nose, mouth, and eyes, as well as the skin and superficial lymph nodes. Cytological examinationis the most commonly used method for definitive diagnosis due to its low cost and fast execution. Chemotherapy, radiotherapy, surgical resection, and other procedures such as cryosurgery are the possible treatment options. The objective ofthis report was to describe a case of extragenital TVT with nasal primary site and metastasis in the bone tissue in a dogtreated at a private veterinary hospital in the city of Belém, Pará, Brazil.Case: A 6-year-old male domiciliary Labrador Retriever dog, weighing 24.2 kg, received oncologic treatment in a privateveterinary hospital in the city of Belém, Pará, Brazil. The animal had a history of neoplastic disease, and he had undergoneTVT resection associated with chemotherapy treatment more than 3 years ago. The clinical examination revealed a volumeincrease in the periorbital region, left lateral ocular displacement, left nostril excessive epistaxis, recurrent sneezing, cough,and pain signs, and tumor metastasis was suspected. Complementary exams of oncological cytology, computed tomography(CT), hemogram, and serum biochemistry were requested for diagnosis and staging of the condition, and supportive therapywas prescribed. The cytological report showed a dense population of neoplastic round cells with characteristics of TVT. CTindicated the presence of a heterogeneous hypodense mass with irregular contours and partially defined limits, with slightuptake of the intravenously injected contrast medium that obliterated the nasal cavity, maxillary recess, nasopharyngealmeatus, frontal sinus, and sphenoid sinus on the left side...

Tumor Venéreo Transmissível (TVT) nasal com metástase óssea em um cão / Nasal transmissible venereal tumor (TVT) with bone metastasis in a dog

Background: Transmissible venereal tumor (TVT) is a highly contagious round cell neoplasm that affects dogs, and itis usually transmitted through coitus. The tumor is mainly located in the genital area; however, the neoplasm can also beextragenital, affecting the nose, mouth, and eyes, as well as the skin and superficial lymph nodes. Cytological examinationis the most commonly used method for definitive diagnosis due to its low cost and fast execution. Chemotherapy, radiotherapy, surgical resection, and other procedures such as cryosurgery are the possible treatment options. The objective ofthis report was to describe a case of extragenital TVT with nasal primary site and metastasis in the bone tissue in a dogtreated at a private veterinary hospital in the city of Belém, Pará, Brazil.Case: A 6-year-old male domiciliary Labrador Retriever dog, weighing 24.2 kg, received oncologic treatment in a privateveterinary hospital in the city of Belém, Pará, Brazil. The animal had a history of neoplastic disease, and he had undergoneTVT resection associated with chemotherapy treatment more than 3 years ago. The clinical examination revealed a volumeincrease in the periorbital region, left lateral ocular displacement, left nostril excessive epistaxis, recurrent sneezing, cough,and pain signs, and tumor metastasis was suspected. Complementary exams of oncological cytology, computed tomography(CT), hemogram, and serum biochemistry were requested for diagnosis and staging of the condition, and supportive therapywas prescribed. The cytological report showed a dense population of neoplastic round cells with characteristics of TVT. CTindicated the presence of a heterogeneous hypodense mass with irregular contours and partially defined limits, with slightuptake of the intravenously injected contrast medium that obliterated the nasal cavity, maxillary recess, nasopharyngealmeatus, frontal sinus, and sphenoid sinus on the left side...(AU)

Princípios e aplicações da betaterapia em medicina veterinária / Principles and applications of beta therapy in veterinary medicine / Principios y aplicaciones de la terapia beta en medicina veterinaria

A betaterapia é uma forma de braquiterapia onde a fonte emissora de raios beta é posicionada diretamente na área em que se deseja tratar. As principais aplicações são em dermatologia e em oftalmologia no tratamento de lesões superficiais, pois as partículas betas têm grande poder de ionização e pequeno alcance no tecido. A radioterapia em medicina veterinária vem aumentando e apresentando resultados satisfatórios no Brasil e pelo mundo. Esta revisão teve como objetivo descrever os princípios e aplicações da betaterapia em medicina veterinária. Para a concretização foi realizada uma pesquisa bibliográfica, possibilitando assim, consolidar informações relativas à base teórica e ao tema proposto. Foi observado o uso do Estrôncio-90 (Sr90) nos principais procedimentos realizados em animais domésticos, selvagens e de experimentação, realçando a importância desta técnica adjuvante. A betaterapia mostrou-se exequível e de fácil manuseio para aplicações em medicina veterinária, especialmente nos casos de lesões e neoplasias superficiais. As fontes radioativas emissoras de partículas betas, como as de Sr90 não requerem grandes cuidados com proteção radiológica, o que contribui para a viabilidade da sua manipulação em radioterapia veterinária, principalmente nos procedimentos intra-operatórios.

Beta therapy is a form of brachytherapy where the beta ray emitting source is positioned directly in the area in which it is desired to be treated. The main applications are in dermatology and ophthalmology in the treatment of superficial lesions, since beta particles have great ionization power and small reach in the tissue. Radiotherapy in veterinary medicine has been increasing and presenting results satisfactory in Brazil and around the world. This review aimed to describe the principles and applications of beta-therapy in veterinary medicine. For the realization, a bibliographic research was carried through, making possible, to consolidate information related to the theoretical base and to the proposed theme. The use of Strontium-90 (Sr90) was observed in the main procedures performed on domestic, wild and experimental animals, highlighting the importance of this adjuvant technique. Beta therapy has been shown to be feasible and easy to handle for veterinary medicine applications, especially in cases of superficial lesions and neoplasms. Beta-emitting radioactive sources, such as those of Sr90, do not require great care with radiological protection, which contributes to the viability of their manipulation in veterinary radiotherapy, especially in intraoperative procedures.

La terapia beta es una forma de braquiterapia en la que la fuente emisora de rayos beta se coloca directamente en el área en la que se desea tratar. Las principales aplicaciones son en dermatología y oftalmología en el tratamiento de lesiones superficiales, porque las partículas beta tienen un gran poder de ionización y un alcance pequeño en el tejido. La radioterapia en medicina veterinaria ha ido aumentando y presentando resultados considerablemente en Brasil y en todo el mundo. Esta revisión tuvo como objetivo describir los principios y aplicaciones de la terapia beta en medicina veterinaria. Para la realización, se realizó una investigación bibliográfica que permitió consolidar información relacionada con la base teórica y el tema propuesto. El uso de Estroncio-90 (Sr90) se observó en los principales procedimientos realizados en animales domésticos, salvajes y experimentales, destacando la importancia de esta técnica adyuvante. Se ha demostrado que la terapia beta es factible y fácil de manejar para aplicaciones veterinarias, especialmente en casos de lesiones superficiales y neoplasias. Las fuentes radiactivas emisoras beta, como las de Sr90, no requieren un gran cuidado con la protección radiológica, lo que contribuye a la viabilidad de su manipulación en radioterapia veterinaria, especialmente en procedimientos intraoperatorios.

Princípios e aplicações da betaterapia em medicina veterinária / Principles and applications of beta therapy in veterinary medicine / Principios y aplicaciones de la terapia beta en medicina veterinaria

A betaterapia é uma forma de braquiterapia onde a fonte emissora de raios beta é posicionada diretamente na área em que se deseja tratar. As principais aplicações são em dermatologia e em oftalmologia no tratamento de lesões superficiais, pois as partículas betas têm grande poder de ionização e pequeno alcance no tecido. A radioterapia em medicina veterinária vem aumentando e apresentando resultados satisfatórios no Brasil e pelo mundo. Esta revisão teve como objetivo descrever os princípios e aplicações da betaterapia em medicina veterinária. Para a concretização foi realizada uma pesquisa bibliográfica, possibilitando assim, consolidar informações relativas à base teórica e ao tema proposto. Foi observado o uso do Estrôncio-90 (Sr90) nos principais procedimentos realizados em animais domésticos, selvagens e de experimentação, realçando a importância desta técnica adjuvante. A betaterapia mostrou-se exequível e de fácil manuseio para aplicações em medicina veterinária, especialmente nos casos de lesões e neoplasias superficiais. As fontes radioativas emissoras de partículas betas, como as de Sr90 não requerem grandes cuidados com proteção radiológica, o que contribui para a viabilidade da sua manipulação em radioterapia veterinária, principalmente nos procedimentos intra-operatórios.(AU)

Beta therapy is a form of brachytherapy where the beta ray emitting source is positioned directly in the area in which it is desired to be treated. The main applications are in dermatology and ophthalmology in the treatment of superficial lesions, since beta particles have great ionization power and small reach in the tissue. Radiotherapy in veterinary medicine has been increasing and presenting results satisfactory in Brazil and around the world. This review aimed to describe the principles and applications of beta-therapy in veterinary medicine. For the realization, a bibliographic research was carried through, making possible, to consolidate information related to the theoretical base and to the proposed theme. The use of Strontium-90 (Sr90) was observed in the main procedures performed on domestic, wild and experimental animals, highlighting the importance of this adjuvant technique. Beta therapy has been shown to be feasible and easy to handle for veterinary medicine applications, especially in cases of superficial lesions and neoplasms. Beta-emitting radioactive sources, such as those of Sr90, do not require great care with radiological protection, which contributes to the viability of their manipulation in veterinary radiotherapy, especially in intraoperative procedures.(AU)

La terapia beta es una forma de braquiterapia en la que la fuente emisora de rayos beta se coloca directamente en el área en la que se desea tratar. Las principales aplicaciones son en dermatología y oftalmología en el tratamiento de lesiones superficiales, porque las partículas beta tienen un gran poder de ionización y un alcance pequeño en el tejido. La radioterapia en medicina veterinaria ha ido aumentando y presentando resultados considerablemente en Brasil y en todo el mundo. Esta revisión tuvo como objetivo describir los principios y aplicaciones de la terapia beta en medicina veterinaria. Para la realización, se realizó una investigación bibliográfica que permitió consolidar información relacionada con la base teórica y el tema propuesto. El uso de Estroncio-90 (Sr90) se observó en los principales procedimientos realizados en animales domésticos, salvajes y experimentales, destacando la importancia de esta técnica adyuvante. Se ha demostrado que la terapia beta es factible y fácil de manejar para aplicaciones veterinarias, especialmente en casos de lesiones superficiales y neoplasias. Las fuentes radiactivas emisoras beta, como las de Sr90, no requieren un gran cuidado con la protección radiológica, lo que contribuye a la viabilidad de su manipulación en radioterapia veterinaria, especialmente en procedimientos intraoperatorios.(AU)

Light-emitting diode stimulates radiodermatitis recovery

Purpose To evaluate the effect of light-emitting diode (LED) in an experimental model of radiodermatitis. Methods Ten male Wistar rats weighing 200250 g were analyzed. Radiation was delivered in a single dose (20 Gy with Strontium-90 dermatological plaques), two areas per animal. After 15 days, they were divided into two groups: control group (n = 5) and LED group (n = 5), which was treated during 21 days later (LED 660 nm, 10 min in alternate days). The endpoints were radiodermatitis scale, histological analysis HE, Picrius Sirius and the gene expression of interleukin-10 (IL-10) and matrix metalloproteinase-9 (MMP-9). Results The LED group showed a higher number of dermal appendages (p = 0.04) and angiogenesis(p = 0.007), a tendency towards higher IL-10 (p = 0.06) and an increase in MMP-9 (p = 0.004) when compared to the control group. Conclusions This study suggested that the use of LED for radiodermatitis increased skin regeneration.(AU)

Sentinel lymph node biopsy using single-agent mapping tracer (blue dye) after neoadjuvant chemotherapy in a Brazilian cohort of breast cancer patients. Real world evidence

ABSTRACT Purpose To reduce false-negative rates (FNR) in sentinel lymph node biopsy (SLNB) of clinically positive (cN+) axilla in patients undergoing neoadjuvant chemotherapy (NAC). The removal of three or more lymph nodes with dual-tracer mapping including a radioisotope was used. However, in the Brazilian Unified Health System, the radioisotope tracer is not feasible in some hospitals. We conducted a cross-sectional study to evaluate the detection rate of sentinel lymph node (SLN) in patients who converted from cN+ to ycN0 after NAC using blue dye as a single-agent mapping tracer. Methods During the period of March 2018 to September 2019, 34 patients who underwent NAC with cN+ who converted to ycN0 were enrolled in the study. The SLNB was performed using blue dye as a single-agent mapping followed by axillary lymph node dissection (ALND). Results The detection rate of sentinel lymph node was of 85.3%, being SLNB not possible for five patients (14.7%), due to fibrosis. The mean number of removed SLN was 2.5. Conclusions The use of blue dye as a single-agent mapping tracer demonstrated an acceptable detection rate of 85.3%. Although the FNR was possible to be determined, the small sample size might overestimate this rate. The removal of three or more lymph nodes with single-agent mapping tracer might be indicated for breast cancer patients who converted to ycN0 after NAC in the Brazilian health public services, in which radioisotope tracer is not suitable.

Evaluation of mesalazine polymeric conjugate in the treatment of actinic proctitis in rats

ABSTRACT Purpose: The present study aimed at testing a new formulation of mesalazine linked to chondroitin sulfate and its components alone in the treatment of actinic proctitis in rats. Methods: Forty-seven female Wistar rats were submitted to pelvic radiation and divided into eight groups: control A, mesalazine A, chondroitin A, and conjugate A, gavage of the according substance two weeks after irradiation and sacrifice three weeks after oral treatment; control C, mesalazine C, chondroitin C, and conjugate C, sacrifice six weeks after oral treatment. The rectum was submitted to histological characterization for each of the findings: inflammatory infiltrate, epithelial degeneration, mucosal necrosis, and fibrosis. Results: The inflammatory infiltrate was more intense in chondroitin A, mesalazine A, and conjugate C. The collagen deposition was less intense in chondroitin A, and mesalazine A, and more intense in control C. Conclusions: Mesalazine and chondroitin alone were efficacious in inducing a delayed inflammatory response, hence reducing the late fibrosis. The conjugate was able to induce an ever more delayed inflammatory response.

Laminotomia dorsal do áxis para excisão de meningioma em cão / Axis dorsal laminotomy for excision of a meningioma in a dog

Background: Surgical access to the spinal cord at the level of C2 vertebra presents technical limitations, due to anatomical particularities in this region. The ventral slot technique does not allow space for the removal of dorsolateral masses. The axis hemilaminectomy technique provides limited access to the dorsal aspect of spinal cord and there is a risk of damaging the vertebral arteries. The axis dorsal laminotomy technique allows good access to spinal cord and preserves the atlantoaxial and nuchal ligaments, however few papers describe this technique. The objective of this paper is to report the axis dorsal laminotomy performed in a dog with a meningioma at this level. Case: An 11-year-old male, Maltese dog, was presented with a 15-day history of progressive weakness, intense cervical pain and difficulty in locomotion of the four limbs. He was being treated with painkillers without improvement. On clinical examination, the physiological parameters were normal. Neurological examination showed tetraparesis with the syndrome localized in the cranial cervical region. The main differential diagnoses were intervertebral disc disease, neoplasia, inflammatory or infectious disease. Computed tomography was performed and the evaluation of images allowed the visualization of an intradural-extramedullary neoplastic process, promoting important spinal compression, with approximate dimensions of the lesion 0.70 cm high x 0.67 cm wide x 0.78 cm long, with apparent involvement of the meninges, with a more lateralized location on the left, with meningioma being the main differential diagnosis. Thus, exploratory surgery, through the technique of dorsal laminotomy of the axis was performed. After the removal of the mass, the spinous process was repositioned in its anatomical location and fixed with 0.6 mm steel cerclage wire that was passed through the holes made in the dorsal lamina of the...

Laminotomia dorsal do áxis para excisão de meningioma em cão / Axis dorsal laminotomy for excision of a meningioma in a dog

Background: Surgical access to the spinal cord at the level of C2 vertebra presents technical limitations, due to anatomical particularities in this region. The ventral slot technique does not allow space for the removal of dorsolateral masses. The axis hemilaminectomy technique provides limited access to the dorsal aspect of spinal cord and there is a risk of damaging the vertebral arteries. The axis dorsal laminotomy technique allows good access to spinal cord and preserves the atlantoaxial and nuchal ligaments, however few papers describe this technique. The objective of this paper is to report the axis dorsal laminotomy performed in a dog with a meningioma at this level. Case: An 11-year-old male, Maltese dog, was presented with a 15-day history of progressive weakness, intense cervical pain and difficulty in locomotion of the four limbs. He was being treated with painkillers without improvement. On clinical examination, the physiological parameters were normal. Neurological examination showed tetraparesis with the syndrome localized in the cranial cervical region. The main differential diagnoses were intervertebral disc disease, neoplasia, inflammatory or infectious disease. Computed tomography was performed and the evaluation of images allowed the visualization of an intradural-extramedullary neoplastic process, promoting important spinal compression, with approximate dimensions of the lesion 0.70 cm high x 0.67 cm wide x 0.78 cm long, with apparent involvement of the meninges, with a more lateralized location on the left, with meningioma being the main differential diagnosis. Thus, exploratory surgery, through the technique of dorsal laminotomy of the axis was performed. After the removal of the mass, the spinous process was repositioned in its anatomical location and fixed with 0.6 mm steel cerclage wire that was passed through the holes made in the dorsal lamina of the...(AU)

Radiation therapy for advanced canine nasal planum squamous cell carcinoma: case report / A utilização da radioterapia no tratamento do carcinoma de células escamosas de plano nasal canino avançado: relato de caso

This case report describes the outcome of treatment of dogs with advanced (deeply invasive) nasal planum squamous cell carcinomas with palliative or definitive radiation therapy. All dogs were diagnosed with nasal planum squamous cell carcinoma by histopathology, and their owners declined aggressive surgery. Dogs were treated with a cobalt-60 unit, definitive-intent radiation protocol consisting of 15 daily fractions (Monday-Friday) of 2.8 Gy, and palliative radiation protocol consisting of 4 fractions of 8 Gy performed once a week. Three dogs had T3 tumors and three had T4 tumors according to the WHO staging system. Two dogs had tumor complete remission and four had tumor partial remission. Survival time of dogs submitted to radiation therapy was 95-417 days. Radiation acute side effects involved only mild epilation and cutaneous erythema in palliative protocols, and moist desquamation, epilation, mild rhinitis and oral mucositis in definitive-intent RT. Radiation therapy, especially palliative protocols, can be a treatment option for nasal planum squamous cell carcinoma in dogs, when the owner declines aggressive surgery. It may contribute to partial or complete tumor remission and better patient quality of life, even at advanced stages, leading to mild side effects.(AU)

Este relato descreve seis casos de carcinoma de células escamosas de plano nasal canino tratados com radioterapia definitiva ou paliativa. Em todos os casos, o diagnóstico definitivo foi feito mediante biópsia, e os tutores declinaram da cirurgia agressiva. A radioterapia foi realizada utilizando-se um equipamento de cobalto-60, e o protocolo definitivo consistiu de 15 frações de 2,8 Gy, cinco vezes por semana (segunda a sexta), enquanto o protocolo paliativo consistiu de quatro frações de 8 Gy, uma vez por semana. Seis cães foram tratados, entre os quais três tinham tumores em estágio T3 e três em estágio T4, de acordo com a tabela TNM da Organização Mundial da Saúde. Dois animais apresentaram remissão completa do tumor após o tratamento e quatro apresentaram remissão parcial. O tempo de sobrevida variou entre 95-417 dias, sendo que dois animais ainda estão vivos e em observação. Os efeitos colaterais da radioterapia foram apenas epilação e eritema leve, no protocolo paliativo, e epilação, radiodermite úmida, rinite e mucosite oral, no protocolo definitivo. A radioterapia, especialmente no protocolo paliativo, pode ser considerada uma opção de tratamento quando os tutores declinam da cirurgia agressiva. Ela pode contribuir para remissão (parcial ou completa) do tumor e melhor qualidade de vida do paciente, mesmo nos casos avançados, levando a efeitos colaterais mínimos.(AU)

Radiation therapy for advanced canine nasal planum squamous cell carcinoma: case report / A utilização da radioterapia no tratamento do carcinoma de células escamosas de plano nasal canino avançado: relato de caso

This case report describes the outcome of treatment of dogs with advanced (deeply invasive) nasal planum squamous cell carcinomas with palliative or definitive radiation therapy. All dogs were diagnosed with nasal planum squamous cell carcinoma by histopathology, and their owners declined aggressive surgery. Dogs were treated with a cobalt-60 unit, definitive-intent radiation protocol consisting of 15 daily fractions (Monday-Friday) of 2.8 Gy, and palliative radiation protocol consisting of 4 fractions of 8 Gy performed once a week. Three dogs had T3 tumors and three had T4 tumors according to the WHO staging system. Two dogs had tumor complete remission and four had tumor partial remission. Survival time of dogs submitted to radiation therapy was 95-417 days. Radiation acute side effects involved only mild epilation and cutaneous erythema in palliative protocols, and moist desquamation, epilation, mild rhinitis and oral mucositis in definitive-intent RT. Radiation therapy, especially palliative protocols, can be a treatment option for nasal planum squamous cell carcinoma in dogs, when the owner declines aggressive surgery. It may contribute to partial or complete tumor remission and better patient quality of life, even at advanced stages, leading to mild side effects.(AU)

Este relato descreve seis casos de carcinoma de células escamosas de plano nasal canino tratados com radioterapia definitiva ou paliativa. Em todos os casos, o diagnóstico definitivo foi feito mediante biópsia, e os tutores declinaram da cirurgia agressiva. A radioterapia foi realizada utilizando-se um equipamento de cobalto-60, e o protocolo definitivo consistiu de 15 frações de 2,8 Gy, cinco vezes por semana (segunda a sexta), enquanto o protocolo paliativo consistiu de quatro frações de 8 Gy, uma vez por semana. Seis cães foram tratados, entre os quais três tinham tumores em estágio T3 e três em estágio T4, de acordo com a tabela TNM da Organização Mundial da Saúde. Dois animais apresentaram remissão completa do tumor após o tratamento e quatro apresentaram remissão parcial. O tempo de sobrevida variou entre 95-417 dias, sendo que dois animais ainda estão vivos e em observação. Os efeitos colaterais da radioterapia foram apenas epilação e eritema leve, no protocolo paliativo, e epilação, radiodermite úmida, rinite e mucosite oral, no protocolo definitivo. A radioterapia, especialmente no protocolo paliativo, pode ser considerada uma opção de tratamento quando os tutores declinam da cirurgia agressiva. Ela pode contribuir para remissão (parcial ou completa) do tumor e melhor qualidade de vida do paciente, mesmo nos casos avançados, levando a efeitos colaterais mínimos.(AU)

Tumor venéreo canino transmissível com metástase mamária / Canine transmissible venereal tumor with mammary metastasis

O tumor venéreo transmissível (TVT) é uma neoplasia canina de elevada incidência e relevância clínica. A transmissão decorre da transplantação de células neoplásicas durante o acasalamento, lambedura, mordedura ou farejamento das regiões acometidas. O diagnóstico baseia-se nos sinais clínicos e exames laboratoriais (exame citológico / exame histopatológico / exame imuno-histoquímico). Diferentes tratamentos (excisão cirúrgica /radioterapia / quimioterapia) são recomendados. O quimioterápico sulfato de vincristina apresenta-se eficaz. Este trabalho teve como objetivo relatar um caso de TVT canino. Uma cadela, sem raça definida (SRD), pesando 9 kg, não castrada, apresentou ao exame clínico ondulações e sangramento progressivo na região genital, além de um nódulo localizado na glândula mamária inguinal direita, sugestivo de TVT. A mesma foi submetida a exames laboratoriais (hemograma completo/exame bioquímico), exame citológico e exame ultrassonográfico abdominal. O diagnóstico citológico confirmou a suspeita de TVT. O quimioterápico sulfato de vincristina na dose de 0,05 mg/kg administrado por via intravenosa quatro vezes a intervalos semanais foi utilizado no tratamento. O diagnóstico citológico após o tratamento demonstrou ausência de células neoplásicas. Em conclusão, o tratamento do TVT utilizando o quimioterápico sulfato de vinscristina demonstrou-se eficaz.

Transmissible venereral tumor (TVT) is a canine neoplasm of high incidence and clinical relevance. Transmission results from the transplantation of neoplastic cells during mating, licking, biting or sniffing of the affected regions. The diagnosis is based on clinical signs and laboratory tests (cytological examination / histopathologic examination / immune histochemical examination). Different treatments (surgical excision / radiotherapy /chemotherapy) are recommended. The chemotherapeutic vincristine sulfate is effective. This study aimed to report a case of canine TVT. A dog, without defined breed (SRD), weighing 9 kg, uncastrated, presenting nodulations and progressive bleeding in the genital region, in addition to a nodule located in the right inguinal mammary gland, suggestive of TVT. The dog was submitted to laboratory tests (complete blood count/biochemical examination), cytological examination and abdominal ultrasound examination. The cytologic diagnosis confirmed the suspicion of TVT. The chemotherapeutic vincristine sulfate at a dose of 0.05 mg/kg administered intravenously four times at weekly intervals was used in the treatment. The cytological diagnosis after treatment showed absence of neoplastic cells. In conclusion, the treatment of TVT using the chemotherapeutic vinscristine sulfate has been shown to be effective.